Over 1,500 bat species carry thousands of deadly viruses but rarely get sick, and scientists are only just beginning to understand whyBats possess a unique, preactivated innate immune defense that stops viruses from fully replicating, even after cell entry. This remarkable...
11 Jun, 2026, 04.55 PM IST
Avammune’s big bet: Why the future of cancer treatment may come in a pillAs global oncology races toward next-generation therapies, Avammune Therapeutics is betting on affordable, orally administered immunotherap...
03 Jun, 2026, 02.36 PM IST
Cipla is aiming for 40-50 global product filings in three years, says MD Achin GuptaCipla is charting its next growth phase with a strong focus on innovation, complex generics, and biosimilars. The company plans significant...
29 May, 2026, 05.30 AM IST
Innovation, biosimilars, complex generics to drive Cipla's growth: Achin Gupta, MD & Group CEOAs Cipla approaches its centenary, the company is redefining its strategy by prioritizing innovation to amplify revenues. With ambitions to...
29 May, 2026, 12.57 AM IST
There are bulls and bears, and also ducks. When Warren Buffett warned against being a stock market duckWarren Buffett mentioned a metaphor that should haunt every investor who has ever felt clever during a rising market: The preening duck tha...
28 May, 2026, 10.06 PM IST
Ebola vaccine update: Russia claims a breakthrough; Oxford researchers, Serum Institute of India aim to begin trial in 3 monthsA new Ebola vaccine developed by Russian scientists shows promise against the current outbreak strain in the Democratic Republic of Congo. ...
27 May, 2026, 12.24 PM IST
Hantavirus scientists were close to vaccine but ran out of moneyScientists in Chile developed antibodies that successfully neutralised the deadly Andes hantavirus in lab and animal studies, raising hopes...
14 May, 2026, 06.53 AM IST
India turns the tables on China: The great supply chain flip beginsIndia's electronics sector is transforming. For years, the country assembled products using imported parts. Now, Indian companies are expor...
17 Apr, 2026, 08.28 PM IST
Gilead to buy Germany's Tubulis for up to $5 billion to boost cancer pipelineGilead is making headlines with its planned acquisition of Tubulis GmbH, a Germany-based company, for a maximum of five billion dollars. Th...
07 Apr, 2026, 08.58 PM IST
Covid-19's surprising link to Cancer treatment: New study shows tumour shrinkage potentialResearchers have discovered that the Covid-19 virus may hold unexpected benefits for cancer treatment. The virus triggers the formation of ...
18 Nov, 2024, 08.36 PM IST
'Unusual' form of cell death underlies lung damage in Covid patients, finds studyFerroptosis, a less common cell death type, is linked to severe lung damage in Covid patients, causing inflammation and respiratory complic...
20 May, 2024, 06.45 PM IST
Researchers find new antibody that can help block Covid transmission in cellsThis approach can prove to be effective against emerging Covid variants.
15 Feb, 2022, 09.08 AM IST
New research hints at 4 factors that may increase chances of long COVIDNow, a team of researchers who followed more than 200 patients for two to three months after their COVID diagnoses report that they have id...
26 Jan, 2022, 05.21 PM IST
Covid: Why T cell vaccines could be the key to long-term immunityEvidence directly on COVID and T cells is still being gathered. However, it's gradually becoming clearer that T cells do seem to play a big...
17 Jan, 2022, 01.48 PM IST
'T cells may offer long-lasting Covid shield, research shows'"We will be sharing the data and findings soon," an official said, underlining that discussion about need for repeat vaccination or even a ...
06 Aug, 2021, 12.11 PM IST
Early antiviral response in nose may determine severity of COVID-19: StudyResearchers from Massachusetts Institute of Technology (MIT) and Harvard University in the US analysed whether the path towards severe dise...
26 Jul, 2021, 12.24 PM IST
Persistence of 'abnormal fused cells' may cause lung damage in Covid patientsThe formation of fused cells is due to the viral spike protein, which corona uses to enter the cell.
05 Nov, 2020, 02.39 PM IST